Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Small-Cap Recap: Fiscal 2016 Spells Sea Change For Angle; Cellnovo; Novacyt; Nanobiotix

Executive Summary

A status update on four startups working in the molecular diagnostics and radiotherapy sectors.

You may also be interested in...

New Data Boosts Nanobiotix's Radiotherapy-Transformation Strategy

Nanobiotix gains more clinical evidence to support its nanoparticle technology in combination with radiotherapy to enhance treatment outcomes in cancer patients.

Angle Strikes Out Into New Cancer Dx Markets

Angle is moving ahead with plans to take its Parsortix circulating tumor cell capture technology into the prostate and breast cancer diagnostic markets after securing £10.2m ($15m) in new capital through a share placement.

Cellnovo Gets Early Foothold In US Diabetes Market With TypeZero Partnership

Cellnovo's partnership with US start-up TypeZero Technologies and its participation in an upcoming international artificial pancreas trial will allow the company to gain an early foothold in the US market before seeking FDA clearance for its diabetes management system, said to be the first and only one of its kind to have an insulin patch pump with mobile connectivity features.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts